Tenaya Therapeutics Inc (NASDAQ:TNYA) does about 3.59M shares in volume on a normal day but saw 1732461 shares change hands in the recent trading day. The company now has a market cap of 73.82M USD. Its current market price is $0.45, marking an increase of 5.44% compared to the previous close of $0.43. The 52 week high reached by this stock is $4.60 whilst the lowest price level in 52 weeks is $0.36.
The consensus objective for the share price is $10.14, suggesting that the stock has a potential upside of 95.56% over the period.
FactSet Research has provided data showing that 3 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 3 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
H.C. Wainwright initiated its price target at $25.
The current price level is 0.15%, -10.96%, and -70.87% away from its SMA20, SMA50, and SMA200 respectively, with the TNYA price moving above the 50-day SMA on current market day. Tenaya Therapeutics Inc (TNYA) stock is down -7.01% over the week and -7.61% over the past month. Its price is -68.27% year-to-date and -89.73% over the past year.
To reach the target analysts have set, the stock logically needs to grow 95.56 percent from here.
Outstanding shares total 162.66M with insiders holding 0.72% of the shares and institutional holders owning 59.73% of the company’s common stock. The company has a return on investment of -81.66% and return on equity of -76.21%. The beta has a value of 2.90. Price to book ratio is 0.62.
